Back to School: How biopharma can reboot drug development. Access exclusive analysis here

VEGF Trap aflibercept: Phase III started

REGN began a double-blind, placebo-controlled, international Phase III trial in 1,200

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE